Nanoscale · 2015 · 74 citations · 37 references
Life SciencesCancer BiologyOncologyApoptosisMolecular OncologyTumor MicroenvironmentCancer NanomedicineLysosomal BiochemistryLysosome BiologyNanomedicineOxidative Damage To BiomoleculesReactive Oxygen SpeciesLysosomal AcidificationLysosomal Ph RegulationLysosome PathwayPh-responsive MaterialsReactive Oxygen Species-responsive NanoparticlesSelective Cancer Therapy
Excess reactive oxygen species (ROS) have been proved to damage cancer cells efficiently. ROS overproduction is thus greatly desirable for cancer therapy. To date, ROS production is generally uncontrollable and outside cells, which always bring severe side-effects in the vasculature. Since most ROS share a very short half-life and primarily react close to their site of formation, it would be more efficient if excess ROS are controllably produced inside cancer cells. Herein, we report an efficient lysosome-controlled ROS overproduction via a pH-responsive catalytic nanosystem (FeOx-MSNs), which catalyze the decomposition of H2O2 to produce considerable ROS selectively inside the acidic lysosomes (pH 5.0) of cancer cells. After a further incorporation of ROS-sensitive TMB into the nanosystem (FeOx-MSNs-TMB), both a distinct cell labeling and an efficient death of breast carcinoma cells are obtained. This lysosome-controlled efficient ROS overproduction suggests promising applications in cancer treatments.
37
Intrinsic peroxidase-like activity of ferromagnetic nanoparticles
Lizeng Gao, Jie Zhuang, Leng Nie et al. · Nature Nanotechnology · 2007 · 7.3K citations
Oxygen Poisoning and X-irradiation: A Mechanism in Common
R. Gerschman, Daniel L. Gilbert, Sylvanus W. Nye et al. · Science · 1954 · 956 citations
Layer-by-layer Nanoarchitectonics: Invention, Innovation, and Evolution
Katsuhiko Ariga, Yusuke Yamauchi, Gaulthier Rydzek et al. · Chemistry Letters · 2013 · 843 citations